Merrimack Pharmaceuticals, Inc. Net Profit Margin 2012-2024 | MACK

Merrimack Pharmaceuticals, Inc. net profit margin from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2015-09-30 $0.10B $-0.11B -108.82%
2015-06-30 $0.11B $-0.10B -84.21%
2015-03-31 $0.11B $-0.09B -86.67%
2014-12-31 $0.10B $-0.08B -81.55%
2014-09-30 $0.08B $-0.11B -138.96%
2014-06-30 $0.06B $-0.12B -212.50%
2014-03-31 $0.05B $-0.13B -284.78%
2013-12-31 $0.05B $-0.13B -272.92%
2013-09-30 $0.05B $-0.12B -224.07%
2013-06-30 $0.06B $-0.10B -179.31%
2013-03-31 $0.05B $-0.09B -180.77%
2012-12-31 $0.05B $-0.09B -189.58%
2012-09-30 $0.05B $-0.09B -187.23%
2012-06-30 $0.05B $-0.09B -191.11%
2012-03-31 $0.04B $-0.10B -242.50%
2011-12-31 $0.04B $-0.09B -248.57%